Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases

Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases

Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The prognosis is often very poor with median overall survival ranging from 6...

Full description

Bibliographic Details
Main Authors: Louis Gros, Petr Szturz, Antonella Diciolla, Volker Kirchner, Solange Peters, Niklaus Schaefer, Martin Hubner, Antonia Digklia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
peritoneal mesothelioma
lurbinectedin
case report
palliative chemotherapy
peritoneal tumor
durable response
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.704295/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.704295/full

Similar Items